Molecule gene analysis of bone absorption in bone reproduction medical care and development of bone absorption restraint medicine
骨再生医疗中骨吸收的分子基因分析及骨吸收抑制药物的开发
基本信息
- 批准号:15390614
- 负责人:
- 金额:$ 9.54万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Intramuscular injection (1 mg/kg) did immunity restraint agent FK506 to a nude mouse and a mouse of a wild type that a T cell suffered a loss day after day on 28th and made an osteoporosis model mouse to search a cell pro-immunity and relevance with the onset of osteoporosis by immunity restraint agent. As a result, as for the bone absorption of a group of experiments by FK506, decrease of trabecula bone was recognized by a wild type more underneath than enchondral ossification, and, as for positive osteoclast, numbers increased in enchondral ossification for TRAP dyeing more clearly than a group of control again. However, as for the bone absorption in the lower part, as for the osteoporosis by immunity restraint agent, what an immunity system cell such as a T cell was related to was suggested without most than enchondral ossification with a nude mouse by there not being control and a change.I discovered that osteoporosis recovered when we administered Propion acid bacteria fermentatio … More n product (PC) that was a starter of Swiss cheese to this osteoporosis model. We examined a bone absorption restraint effect from this fermentation product this time. I was able to prevent the bone absorption when I administered Propion acid bacteria fermentation product (PC) to an osteoporosis mouse by FK506.In late years a lot of existing DHNA has a naphthoquinone frame the same as vitamins K2 attracting attention in a quantity of bone salt thing having quantity of bone improvement action within a PC.I paid attention to this point, and we accepted bone absorption restraint same as a PC for an osteoporosis model when we administered DHNA alone. As for DHNA, the bone absorption restraint effect of a PC was able to identify a thing by DHNA from what was included in a PC abundantly.I compared osteoclast with control when I added the B cell which was a T cell and the B220 positive that were four twist CD positive in marrow in osteoclast of a mouse namely in vitro of bone bud cell-like strike Rome cell and marrow cell with magnetic beads and increased significantly. Less
肌内注射(1 mg/kg)对裸鼠和野生型的小鼠进行了免疫震动剂FK506,T细胞日复一日地遭受了损失,并使骨质疏松型鼠标搜索了骨气造成的骨气免疫性,并与免疫疾病的骨质渗透剂的发作相关。结果,至于FK506通过FK506的一组实验的骨质损失,小梁骨的减少是通过在链接骨化的下方的野生型识别的,而对于阳性破骨细胞,链接骨化的数量增加了捕集诱捕的诱捕性染料的数量,而不是一组控制。然而,至于下部的骨骼遭受骨骼的痛苦,与免疫抗衡剂的骨质疏松症一样,建议没有大多数的免疫系统细胞(例如T细胞),而没有大多数与裸子用裸子骨化相关的,没有控制和变化。骨质疏松模型。这次我们检查了该发酵产品的骨损失约束作用。当我将丙酸细菌发酵产品(PC)施用到骨质疏松小鼠时,我能够防止骨骼损失,FK506在深近几年中,许多现有的DHNA具有萘季型框架,与维生素K2相同,与骨头损失的骨骼损失相同,在PC上占据了骨骼的骨骼损失,从而吸引了PC。骨质疏松模型时,当我们单独管理DHNA时。至于DHNA,PC的骨损失约束效应能够从PC中透露DHNA的一件事。当我添加B细胞时,将破骨细胞与对照组相比,它是T细胞和B220阳性的b220阳性,这些tw Twist CD是骨髓中的骨髓中的四个Twist CD阳性,它在骨纤维细胞中的骨细胞中均与骨骼般的细胞型细胞和型号beach型bex cy相比。较少的
项目成果
期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
骨粗鬆症学-基礎・臨床研究の新しいパラダイム 免疫抑制剤が引き起こす骨粗懸症(62巻増刊号2)
骨质疏松科学——基础与临床研究新范式:免疫抑制药物引起的骨质疏松(第62卷特刊2)
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:菅原利夫;福永城司
- 通讯作者:福永城司
Toshio Sugahara, Makoto Nakano et al.: "Expression Pattern of Cisplatin-Induced Metallothionein Isoforms in Squamous Cell Carcinoma"Anticancer Research. 23. 299-304 (2003)
Toshio Sugahara、Makoto Nakano 等:“鳞状细胞癌中顺铂诱导的金属硫蛋白亚型的表达模式”抗癌研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Pathological change of articular cartilage in the mandibular head treated with immunosuppressant FK506
免疫抑制剂FK506治疗下颌骨头关节软骨的病理变化
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Jyoji Fukunaga;Takaaki Ueno et al.
- 通讯作者:Takaaki Ueno et al.
Vascular Endothelial Growth Factor(VEGF) and Bone Morphogenetic Protein-4(BMP-4) in Endochondra Ossification from Grafted Periosteum
血管内皮生长因子(VEGF)和骨形态发生蛋白-4(BMP-4)在移植骨膜软骨内骨化中的作用
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Toshio Sugahara;Takaaki Ueno et al.
- 通讯作者:Takaaki Ueno et al.
Toshio Sugahara, Takaaki Ueno et al.: "Vascular Endothelial Growth Factor(VEGF)and Bone Morphogenetic Protein-4(BMP-4) in Endochondra Ossification from Grafted Periosteum"Acta Histochemistry Cytochemistry. 36(1). 61-66 (2003)
Toshio Sugahara、Takaaki Ueno 等人:“血管内皮生长因子 (VEGF) 和骨形态发生蛋白 4 (BMP-4) 在移植骨膜内软骨骨化中的作用”组织化学细胞化学学报。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
共 19 条
- 1
- 2
- 3
- 4
SUGAHARA Toshio的其他基金
Research on metabolic mechanism of palatal processes and cleft palate onset mechanism from genes
从基因角度研究腭突代谢机制及腭裂发病机制
- 批准号:16K1177216K11772
- 财政年份:2016
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Localization of Perlecan and Heparanase in the Epithelial
基底膜聚糖和乙酰肝素酶在上皮细胞中的定位
- 批准号:2259226922592269
- 财政年份:2010
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Scientific Research (C)Grant-in-Aid for Scientific Research (C)
Molecular and genetic analysis of osteoclast differentiantion factor and osteoclastgenesis inhibitory factor in osteoporosis and control of inhibition of bone resorption by 1, 4-dihydroxy-2-naphthoic acid(DHNA)
破骨细胞分化因子和破骨细胞生成抑制因子在骨质疏松症中的分子和遗传学分析及1, 4-二羟基-2-萘甲酸(DHNA)抑制骨吸收的控制
- 批准号:1939051619390516
- 财政年份:2007
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Scientific Research (B)Grant-in-Aid for Scientific Research (B)
The study of molecular and gene analysis and bone metabolism-improving effect of propiomibacterium freudenreichii milk whey culture against osteoporosis.
费氏丙酸杆菌乳清培养物抗骨质疏松的分子基因分析及骨代谢改善作用研究
- 批准号:1739053817390538
- 财政年份:2005
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Scientific Research (B)Grant-in-Aid for Scientific Research (B)
A design and manufacture using CAD and CAE system, and its clinical application
利用CAD和CAE系统设计制造及其临床应用
- 批准号:1347043513470435
- 财政年份:2001
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Scientific Research (B)Grant-in-Aid for Scientific Research (B)
Clinical application of our developed artificial temporomandibular joint. 1)study on respiratory function, especially sleep apnea syndrome, 2)study on jaw movement
我们研制的人工颞下颌关节的临床应用。
- 批准号:1047043310470433
- 财政年份:1998
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Scientific Research (B).Grant-in-Aid for Scientific Research (B).
THE STUDY OF A JAW MOVEMENT BEFORE AND AFTER TOTAL TMJ REPLACEMENT
全颞下颌关节置换术前后下颌运动的研究
- 批准号:0845754808457548
- 财政年份:1996
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Scientific Research (B)Grant-in-Aid for Scientific Research (B)
Development of a simulator for educational oral surgery using virtual reality
使用虚拟现实开发口腔外科教育模拟器
- 批准号:0855711508557115
- 财政年份:1996
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Scientific Research (A)Grant-in-Aid for Scientific Research (A)
Development of artificial tempolomandibular joint
人工颞下颌关节的研制
- 批准号:0555709005557090
- 财政年份:1993
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Developmental Scientific Research (B)Grant-in-Aid for Developmental Scientific Research (B)
Investigation into Pre and Post Operative Functional Changes of Jaw Movement and Oral Cavity Related Muscles of Maxillofacial Deformaties.
颌面畸形下颌运动和口腔相关肌肉手术前后功能变化的调查。
- 批准号:0445450104454501
- 财政年份:1992
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for General Scientific Research (B)Grant-in-Aid for General Scientific Research (B)
相似国自然基金
肿瘤分泌的CTHRC1介导ITGB3依赖的破骨细胞分化促进前列腺癌骨转移的机制研究
- 批准号:82303472
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
重度肥胖状态下骨髓中MAIT细胞活化促进破骨细胞分化及骨吸收的作用及机制研究
- 批准号:82300991
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
破骨细胞通过Tctex-1外泌体途径促进软骨细胞基质小泡释放及OA早期软骨钙化的机制研究
- 批准号:82302747
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于S1P-S1PR1-RANKL信号轴调控成骨-破骨细胞耦合平衡探究黄连生物碱代谢物治疗糖尿病型骨质疏松症的作用机制
- 批准号:82305270
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
IFT20通过影响伪足小体组装及其机械力信号转导调控破骨细胞骨吸收的机制研究
- 批准号:32370816
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:24K1923724K19237
- 财政年份:2024
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Early-Career ScientistsGrant-in-Aid for Early-Career Scientists
Mechanisms of osteocyte induction and regulation of pathogen-induced osteolysis
骨细胞诱导机制和病原体引起的骨溶解的调节
- 批准号:1064851310648513
- 财政年份:2023
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:
Drug delivery system of osteoclast differentiation inhibitor with carbonate apatite
碳酸磷灰石破骨细胞分化抑制剂的给药系统
- 批准号:23K1604423K16044
- 财政年份:2023
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Early-Career ScientistsGrant-in-Aid for Early-Career Scientists
Osteoclast fusion and regulation by DC-STAMP and OC-STAMP
DC-STAMP 和 OC-STAMP 的破骨细胞融合和调节
- 批准号:23K1613223K16132
- 财政年份:2023
- 资助金额:$ 9.54万$ 9.54万
- 项目类别:Grant-in-Aid for Early-Career ScientistsGrant-in-Aid for Early-Career Scientists
Osteoclast programming and reprogramming during osteoclastogenesis
破骨细胞生成过程中的破骨细胞编程和重编程
- 批准号:1077611210776112
- 财政年份:2023
- 资助金额:$ 9.54万$ 9.54万
- 项目类别: